Biotech Stocks Touched New Lows: Sequenom Inc. (NASDAQ:SQNM), Sangamo Biosciences Inc. (NASDAQ:SGMO), Celladon Corporation (NASDAQ:CLDN), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Calithera Biosciences (NASDAQ:CALA)

Sequenom, Inc. (NASDAQ:SQNM) reported total revenues of $32.8 million for the second quarter of 2015, a decrease of 18% compared to revenues of $39.8 million for the second quarter of 2014. Sequenom Inc. (NASDAQ:SQNM) belongs to Healthcare sector. Its net profit margin is 20.30% and weekly performance is -16.07%. On last trading day company shares ended up $2.35. Sequenom Inc. (NASDAQ:SQNM) distance from 50-day simple moving average (SMA50) is -24.55%.

Sangamo BioSciences Inc. (NASDAQ:SGMO) on Wednesday reported a loss of $12.1 million in its second quarter. On a per-share basis, the Richmond, California-based company said it had a loss of 17 cents. Sangamo Biosciences Inc. (NASDAQ:SGMO) shares moved down -17.86% in last trading session and ended the day at $7.59. SGMO return on assets is -9.80%. Sangamo Biosciences Inc. (NASDAQ:SGMO) quarterly performance is -40.38%.

Morgan & Morgan reminds investors that securities class actions have been filed in the United States District Court for the Southern District of California on behalf of those who purchased shares of Celladon Corp. (NASDAQ:CLDN), during the period between July 7, 2014 and June 25, 2015, inclusive (the “Class Period”). On 06 August, Celladon Corporation (NASDAQ:CLDN) shares moved down -6.56% and was closed at $1.14. Celladon Corporation (NASDAQ:CLDN) year to date (YTD) performance is -94.16%.

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) on Thursday reported a loss of $38.4 million in its second quarter. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 78 cents. The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 98 cents per share. Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) ended the last trading day at $8.25. Company weekly volatility is calculated as 5.07% and price to cash ratio as 1.74. Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) showed a weekly performance of -5.50%.

Calithera Biosciences, Inc. (NASDAQ:CALA), announced that the Company’s second quarter 2015 financial results will be released on Monday, August 10, 2015. Company management will host a conference call on Monday, August 10, 2015 at 1:30 p.m. Pacific Time/ 4:30 p.m. Eastern Time to discuss the financial results and other recent corporate highlights. Calithera Biosciences, Inc. (NASDAQ:CALA) shares moved down -7.36% in last trading session and ended the day at $6.42. CALA return on assets is -43.40%. Calithera Biosciences, Inc. (NASDAQ:CALA) quarterly performance is -32.56%.

Leave a Reply

Your email address will not be published. Required fields are marked *